Literature DB >> 23344669

[Epidemiology of anaphylaxis].

M Worm1.   

Abstract

Anaphylaxis is the most severe manifestation of a mast cell dependent hypersensitivity reaction. Recent data on epidemiology indicate that food and drug induced anaphylaxis has increased within the last years. The epidemiological data on anaphylaxis vary throughout the world as the overall incidence and also relevant elicitors depend on different endogenous, but also exogenous factors (e.g. ICD-code, life style, comorbidities). Data from the anaphylaxis registry has shown that venom, drugs and foods are the most frequent elicitors for anaphylaxis within German-speaking countries, while the ranking of the elicitors is age-dependent. Risk factors for anaphylaxis are comorbidities like asthma or mastocytosis or other circumstances, which can increase either the relative risk or the severity. Further risk factors are age, gender and the concomitant intake of drugs like ACE inhibitors or acetylsalicylic acid but also exercise. Data on the clinical epidemiology of anaphylaxis are essential to follow up the most frequent elicitors and risk factors over time and accumulate data about diagnostic and therapeutic procedures in patients suffering from a potential fatal manifestation of an IgE-dependent disease. The anaphylaxis registry within the German-speaking area achieved to provide data of the most frequent elicitors, risk factors and the medical treatment from affected individuals to optimize the management of patients with anaphylaxis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23344669     DOI: 10.1007/s00105-012-2449-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  21 in total

1.  Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery system.

Authors:  Carlos Iribarren; Irina V Tolstykh; Mary K Miller; Mark D Eisner
Journal:  Ann Allergy Asthma Immunol       Date:  2010-05       Impact factor: 6.347

2.  Risk factors for severe pediatric food anaphylaxis in Italy.

Authors:  Mauro Calvani; Fabio Cardinale; Alberto Martelli; Antonella Muraro; Neri Pucci; Francesco Savino; Daniela Zappalà; Valentina Panetta
Journal:  Pediatr Allergy Immunol       Date:  2011-09-19       Impact factor: 6.377

Review 3.  Epinephrine and its use in anaphylaxis: current issues.

Authors:  Keith J Simons; F Estelle R Simons
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-08

4.  Time trends in allergic disorders in the UK.

Authors:  R Gupta; A Sheikh; D P Strachan; H R Anderson
Journal:  Thorax       Date:  2006-09-01       Impact factor: 9.139

5.  Symptom profile and risk factors of anaphylaxis in Central Europe.

Authors:  M Worm; G Edenharter; F Ruëff; K Scherer; C Pföhler; V Mahler; R Treudler; R Lang; K Nemat; A Koehli; B Niggemann; S Hompes
Journal:  Allergy       Date:  2012-02-16       Impact factor: 13.146

6.  Provoking allergens and treatment of anaphylaxis in children and adolescents--data from the anaphylaxis registry of German-speaking countries.

Authors:  Stephanie Hompes; Alice Köhli; Katja Nemat; Kathrin Scherer; Lars Lange; Franziska Rueff; Ernst Rietschel; Thomas Reese; Zsolt Szepfalusi; Nicolaus Schwerk; Kirsten Beyer; Thomas Hawranek; Bodo Niggemann; Margitta Worm
Journal:  Pediatr Allergy Immunol       Date:  2011-03-16       Impact factor: 6.377

7.  The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project.

Authors:  Wyatt W Decker; Ronna L Campbell; Veena Manivannan; Anuradha Luke; Jennifer L St Sauver; Amy Weaver; M Fernanda Bellolio; Eric J Bergstralh; Latha G Stead; James T C Li
Journal:  J Allergy Clin Immunol       Date:  2008-11-06       Impact factor: 10.793

8.  Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity.

Authors:  Franziska Ruëff; Bernhard Przybilla; Maria Beatrice Biló; Ulrich Müller; Fabian Scheipl; Werner Aberer; Joëlle Birnbaum; Anna Bodzenta-Lukaszyk; Floriano Bonifazi; Christoph Bucher; Paolo Campi; Ulf Darsow; Cornelia Egger; Gabrielle Haeberli; Thomas Hawranek; Michael Körner; Iwona Kucharewicz; Helmut Küchenhoff; Roland Lang; Oliviero Quercia; Norbert Reider; Maurizio Severino; Michael Sticherling; Gunter Johannes Sturm; Brunello Wüthrich
Journal:  J Allergy Clin Immunol       Date:  2009-11       Impact factor: 10.793

9.  Anaphylaxis fatalities and admissions in Australia.

Authors:  Woei Kang Liew; Elizabeth Williamson; Mimi L K Tang
Journal:  J Allergy Clin Immunol       Date:  2008-12-30       Impact factor: 10.793

10.  Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.

Authors:  K Brockow; C Jofer; H Behrendt; J Ring
Journal:  Allergy       Date:  2008-02       Impact factor: 13.146

View more
  2 in total

Review 1.  [Adverse drug reactions in elderly people : First data from the Leipzig Research Center for Civilization Diseases (LIFE)].

Authors:  R Treudler; F Walther; P Ahnert; J-C Simon
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

2.  Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland.

Authors:  Margitta Worm; Oliver Eckermann; Sabine Dölle; Werner Aberer; Kirsten Beyer; Thomas Hawranek; Stephanie Hompes; Alice Koehli; Vera Mahler; Katja Nemat; Bodo Niggemann; Claudia Pföhler; Uta Rabe; Angelika Reissig; Ernst Rietschel; Kathrin Scherer; Regina Treudler; Franziska Ruëff
Journal:  Dtsch Arztebl Int       Date:  2014-05-23       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.